Literature DB >> 20006608

Sphingolipids and gangliosides of the nervous system in membrane function and dysfunction.

Elena Posse de Chaves1, Simonetta Sipione.   

Abstract

Simple sphingolipids such as ceramide and sphingomyelin (SM) as well as more complex glycosphingolipids play very important roles in cell function under physiological conditions and during disease development and progression. Sphingolipids are particularly abundant in the nervous system. Due to their amphiphilic nature they localize to cellular membranes and many of their roles in health and disease result from membrane reorganization and from lipid interaction with proteins within cellular membranes. In this review we discuss some of the functions of sphingolipids in processes that entail cellular membranes and their role in neurodegenerative diseases, with an emphasis on SM, ceramide and gangliosides. Copyright 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20006608     DOI: 10.1016/j.febslet.2009.12.010

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  89 in total

1.  Phosphatidylinositol 4-phosphate 5-kinase alpha is induced in ganglioside-stimulated brain astrocytes and contributes to inflammatory responses.

Authors:  Sang Yoon Lee; Bokyung Kim; Sarah Yoon; Yeon Joo Kim; Tian Liu; Joo Hong Woo; Yong-Joon Chwae; Eun-hye Joe; Ilo Jou
Journal:  Exp Mol Med       Date:  2010-09-30       Impact factor: 8.718

2.  Parkinsonian GM2 synthase knockout mice lacking mature gangliosides develop urinary dysfunction and neurogenic bladder.

Authors:  Carolina Gil-Tommee; Guadalupe Vidal-Martinez; C Annette Reyes; Javier Vargas-Medrano; Gloria V Herrera; Silver M Martin; Stephanie A Chaparro; Ruth G Perez
Journal:  Exp Neurol       Date:  2018-10-25       Impact factor: 5.330

3.  Etoposide-loaded immunoliposomes as active targeting agents for GD2-positive malignancies.

Authors:  Brandon S Brown; Tariq Patanam; Keyan Mobli; Christian Celia; Peter E Zage; Andrew J Bean; Ennio Tasciotti
Journal:  Cancer Biol Ther       Date:  2014-04-22       Impact factor: 4.742

4.  Histochemical and immunoelectron microscopic analysis of ganglioside GM3 in human kidney.

Authors:  Tetsuya Kaneko; Yoshiharu Tsubakihara; Hiroaki Fushimi; Seiji Yamaguchi; Yoshitsugu Takabatake; Hiromi Rakugi; Hayato Kawakami; Yoshitaka Isaka
Journal:  Clin Exp Nephrol       Date:  2014-07-02       Impact factor: 2.801

Review 5.  β-Amyloid aggregation and heterogeneous nucleation.

Authors:  Atul K Srivastava; Jay M Pittman; Jonathan Zerweck; Bharat S Venkata; Patrick C Moore; Joseph R Sachleben; Stephen C Meredith
Journal:  Protein Sci       Date:  2019-08-06       Impact factor: 6.725

6.  An optimized method for measuring fatty acids and cholesterol in stable isotope-labeled cells.

Authors:  Joseph P Argus; Amy K Yu; Eric S Wang; Kevin J Williams; Steven J Bensinger
Journal:  J Lipid Res       Date:  2016-12-14       Impact factor: 5.922

Review 7.  Linking lipids to Alzheimer's disease: cholesterol and beyond.

Authors:  Gilbert Di Paolo; Tae-Wan Kim
Journal:  Nat Rev Neurosci       Date:  2011-03-30       Impact factor: 34.870

8.  FTY720 Improves Behavior, Increases Brain Derived Neurotrophic Factor Levels and Reduces α-Synuclein Pathology in Parkinsonian GM2+/- Mice.

Authors:  Guadalupe Vidal-Martinez; Katherine Najera; Julie D Miranda; Carolina Gil-Tommee; Barbara Yang; Javier Vargas-Medrano; Valeria Diaz-Pacheco; Ruth G Perez
Journal:  Neuroscience       Date:  2019-05-23       Impact factor: 3.590

9.  Effects of gangliosides on the activity of the plasma membrane Ca2+-ATPase.

Authors:  Lei Jiang; Misty D Bechtel; Jennifer L Bean; Robert Winefield; Todd D Williams; Asma Zaidi; Elias K Michaelis; Mary L Michaelis
Journal:  Biochim Biophys Acta       Date:  2014-01-14

Review 10.  The Pathogenic Role of Ganglioside Metabolism in Alzheimer's Disease-Cholinergic Neuron-Specific Gangliosides and Neurogenesis.

Authors:  Toshio Ariga
Journal:  Mol Neurobiol       Date:  2017-01       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.